These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36271897)

  • 41. Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura.
    Racine-Brzostek SE; Shi PA
    Transfusion; 2019 Aug; 59(8):2496-2498. PubMed ID: 31283011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of thrombotic thrombocytopenic purpura].
    Galstyan GM; Maschan AA; Klebanova EE; Kalinina II
    Ter Arkh; 2021 Jun; 93(6):736-745. PubMed ID: 36286842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.
    Velásquez Pereira LC; Roose E; Graça NAG; Sinkovits G; Kangro K; Joly BS; Tellier E; Kaplanski G; Falter T; Von Auer C; Rossmann H; Feys HB; Reti M; Prohászka Z; Lämmle B; Voorberg J; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K
    J Thromb Haemost; 2021 Feb; 19(2):478-488. PubMed ID: 33171004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
    Kubo K; Abe T; Kawano N; Ochiai H
    Am J Case Rep; 2021 Aug; 22():e932251. PubMed ID: 34334786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism.
    Okumura T; Hashimoto K; Aomura D; Kurasawa Y; Hara Y; Fujii K; Masuda T; Sonoda K; Yamaguchi A; Ogawa Y; Kamijo Y
    Intern Med; 2020 Mar; 59(5):715-719. PubMed ID: 31708547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P; Froissart A;
    Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
    Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura.
    Kangro K; Roose E; Joly BS; Sinkovits G; Falter T; von Auer C; Rossmann H; Reti M; Voorberg J; Prohászka Z; Lämmle B; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K
    Blood Adv; 2021 Sep; 5(17):3427-3435. PubMed ID: 34495312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications.
    Dainese C; Valeri F; Pizzo E; Valpreda A; Sivera P; Montaruli B; Porreca A; Massaia M; Bruno B; Borchiellini A
    Clin Appl Thromb Hemost; 2022; 28():10760296221125785. PubMed ID: 36124377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura.
    Prasannan N; Dragunaite B; Subhan M; Thomas M; de Groot R; Singh D; Vanhoorelbeke K; Scully M
    Blood; 2024 Jun; 143(25):2644-2653. PubMed ID: 38502824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.
    Galbusera M; Bresin E; Noris M; Gastoldi S; Belotti D; Capoferri C; Daina E; Perseghin P; Scheiflinger F; Fakhouri F; Grünfeld JP; Pogliani E; Remuzzi G
    Blood; 2005 Aug; 106(3):925-8. PubMed ID: 15827129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clopidogrel-induced refractory thrombotic thrombocytopenic purpura successfully treated with rituximab.
    Khodor S; Castro M; McNamara C; Chaulagain CP
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):76-9. PubMed ID: 26684918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic thrombocytopenic purpura that developed 3 years after systemic lupus erythematosus had remitted with rituximab therapy.
    Tsuda R; Kido T; Okada I; Kobiyama A; Kawataka M; Yamazaki M; Asano R; Hounoki H; Shinoda K; Tobe K
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):57-62. PubMed ID: 37341710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The standard of care for immune thrombotic thrombocytopenic purpura today.
    Zheng XL
    J Thromb Haemost; 2021 Aug; 19(8):1864-1871. PubMed ID: 34060225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
    Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.
    Browning S; Bahar B; Lee AI; Gorshein E
    Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
    Mazepa MA; Park YA; Raval JS
    Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current management of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA; Meyer SC
    Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.